BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2014 7:49:00 PM | Browse: 1012 | Download: 949
Publication Name World Journal of Gastroenterology
Manuscript ID 9082
Country China
Received
2014-01-20 08:35
Peer-Review Started
2014-01-20 14:05
To Make the First Decision
2014-02-14 14:16
Return for Revision
2014-02-18 11:50
Revised
2014-03-10 07:59
Second Decision
2014-05-05 09:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-05 09:54
Articles in Press
2014-05-23 10:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-05-16 22:29
Typeset the Manuscript
2014-08-28 09:57
Publish the Manuscript Online
2014-09-18 19:50
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: A meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Xiao Li, Li-Ping Tao and Chun-Hui Wang
Funding Agency and Grant Number
Corresponding Author Chun-Hui Wang, MD, Department of Gastroenterology, West China Hospital of Sichuan University, No. 37 Guoxuexiang, Wuhou District, Chengdu 610041, Sichuan Province, China. dwangsc@sina.com
Key Words Nonsteroidal anti-inflammatory drugs; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Randomized controlled trial; Meta-analysis
Core Tip This meta-analysis was designed to compare the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in the presence or absence of prophylactic nonsteroidal anti-inflammatory drug (NSAID) administration after ERCP. A total of eight studies were included in the pooled analysis and contained 1883 patients that underwent ERCP with 971 patients in the NSAID group and 912 patients in the control group. Patients receiving NSAIDs after ERCP had a reduced incidence of PEP when compared with the placebo group, though NSAID administration did not reduce the incidence of moderate to severe pancreatitis.
Publish Date 2014-09-18 19:50
Citation Li X, Tao LP, Wang CH. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: A meta-analysis. World J Gastroenterol 2014; 20(34): 12322-12329
URL http://www.wjgnet.com/1007-9327/full/v20/i34/12322.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i34.12322
Full Article (PDF) WJG-20-12322.pdf
Full Article (Word) WJG-20-12322.doc
Manuscript File 9082-Review.docx
Answering Reviewers 9082-Answering reviewers.pdf
Copyright License Agreement 9082-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9082-Language certificate.pdf
Peer-review Report 9082-Peer review(s).pdf
Scientific Editor Work List 9082-Scientific editor work list.pdf